Published Paper Details:

Because of the related morbidity, death, and societal economic costs, hypertension continues to be a major public health problem. It poses a considerable risk for renal, cardiovascular, and cerebrovascular issues. 1.56 billion people will develop hypertension by the year 2025, according to predictions. The prevalence of hypertension is rising, and the cost of treating it is also rising, which has an impact on how often doctors prescribe certain medications and how well their patients adhere to their treatment plans. The management of hypertension is covered in a variety of published national and international recommendations. Since many years ago, diuretics have been recommended as first-line medications for the treatment of hypertension. However, the Joint National Commission's most recent guidelines (the JNC8 guidelines) also recommend calcium channel blockers and angiotensin-converting enzyme inhibitors as first-line medications, in addition to diuretics. For long-term management and the treatment of comorbid disorders, antihypertensive medication combinations are often employed. This study focuses on how antihypertensive drugs are used, how much they cost, how well patients follow their treatment plans, and how closely doctors follow prescription drug standards in various contexts, including the Indian context.